1. Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET. (March 2014) Authors: Ridler, Khanum; Gunn, Roger N; Searle, Graham E; Barletta, Julien; Passchier, Jan; Dixson, Luanna; Hallett, William A; Ashworth, Sharon; Gray, Frank A; Burgess, Clare; Poggesi, Italo; Bullman, Jonathan N; Ratti, Emiliangelo; Laruelle, Marc A; Rabiner, Eugenii A Journal: Journal of psychopharmacology Issue: Volume 28:Number 3(2014:Mar.) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol‐intoxicated volunteers. (8th April 2013) Authors: te Beek, Erik T.; Hay, Justin L.; Bullman, Jonathan N.; Burgess, Clare; Nahon, Kimberly J.; Klaassen, Erica S.; Gray, Frank A.; van, Joop M. A. Journal: British journal of clinical pharmacology Issue: Volume 75:Number 5(2013:May) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗